Exon 20 Group, a multi-stakeholder organization
@exon20group
Global org: patients/carers, HCPs, pharma, labs, scientists, working to cure #NSCLC #HER2 & #EGFR #Exon20 insertions (in 25 cancers +) [email protected]
ID: 884565534288756736
https://exon20group.org/ 11-07-2017 00:10:32
1,1K Tweet
1,1K Takipçi
3,3K Takip Edilen
A new study by the American Cancer Society Cancer Action Network finds the 340B program creates incentives for hospitals to use more expensive medications, thus increasing the amount cancer patients pay in deductibles, coinsurance, and for medications. Governor Tina Kotek, please veto